Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1285
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03749421 | Prospective Study of the Prosigna Assay on Neoadjuvant Clinical Decision-making in Women With HR+/Her2- Breast Cancer | ||
| NCT03331406 | Physical Activity In Gastrointestinal Cancer | ||
| NCT03093428 | Study Evaluating the Addition of Pembrolizumab to Radium-223 in mCRPC | ||
| NCT04572763 | Copanlisib Plus Venetoclax in R/R DLBCL | ||
| NCT03414684 | Carboplatin +/- Nivolumab in Metastatic Triple Negative Breast Cancer | ||
| NCT00116506 | Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal Cancer | ||
| NCT00936858 | RAD001 for Patients With Radioiodine Refractory Thyroid Cancer | ||
| NCT05327465 | Exercise to Enhance Cardiovascular Health Among Black Prostate Cancer Patients With Androgen Deprivation Therapy | ||
| NCT04895436 | Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL) | ||
| NCT01978899 | Healthy Living After Cancer: Weight Management Pilot Study | ||
| NCT01299038 | Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer | ||
| NCT01164956 | Methylphenidate for Cancer-Related Fatigue | ||
| NCT01746173 | CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma | ||
| NCT00134654 | Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancer | ||
| NCT03735446 | Prexasertib in Combination With MEC in Relapsed/Refractory AML and High Risk MDS - a Phase I Trial | ||
| NCT04846478 | Phase Ia/Ib Talazoparib + Tazemetostat for mCRPC | ||
| NCT06563596 | Epco, Zanu, Ritux for R/R FL or MZL | ||
| NCT01368003 | STA-9090 in Castration-Resistant Prostate Cancer With Assessment of Androgen Receptor Pathway Signaling | ||
| NCT00146588 | Cytoxan, Epirubicin and Capecitabine in Women With Breast Cancer | ||
| NCT05356117 | Resistance Exercise Combined With Protein Supplementation in People With Pancreatic Cancer: The RE-BUILD Trial | ||
| NCT04906096 | Paxalisib (GDC-0084) In Recurrent Or Refractory PCNSL | ||
| NCT00165438 | Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy | ||
| NCT00361621 | Ph II CHOP+Velcade in Mediastinal LBCL | ||
| NCT01000155 | Efficacy of Vorinostat to Induce Fetal Hemoglobin in Sickle Cell Disease | ||
| NCT06692452 | Tazemetostat Plus CHOP in 1L T-cell Lymphoma | ||
| NCT05375643 | SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention) | ||
| NCT00422799 | Combination Bortezomib and Rituximab in Patients With Waldenstrom's Macroglobulinemia (WM) | ||
| NCT02770014 | Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer | ||
| NCT01484314 | Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma | ||
| NCT05774899 | CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC | ||
| NCT01844999 | Personal Patient Profile - Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care Networks | ||
| NCT00125021 | Tarceva and Capecitabine for Pancreatic Cancer | ||
| NCT01972516 | Tivozanib As Maintenance Therapy In GYN | ||
| NCT01838564 | The PediQUEST Study: Evaluation of Pediatric Quality of Life and Evaluation of Symptoms Technology | ||
| NCT06479187 | PSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate Cancer | ||
| NCT06239220 | PD-L1 t-haNK, N-803 IL-15sa and Cetuximab for Recurrent, Metastatic HNSCC | ||
| NCT03974217 | Talazoparib for Cohesin-Mutated AML and MDS With Excess Blasts | ||
| NCT04033497 | Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases | ||
| NCT02644382 | Improving Surgical Decision-making in Young Women With Breast Cancer | ||
| NCT03426878 | Cancer Health Assessments Reaching Many | ||
| NCT02783625 | Trial of Duvelisib in Combination With Either Romidepsin or Bortezomib in Relapsed/Refractory T-cell Lymphomas | ||
| NCT02582697 | Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours | ||
| NCT03455764 | MCS110 With BRAF/MEK Inhibition in Patients With Melanoma | ||
| NCT00142181 | Phase II Study of Campath-1H Antibody to Treat Waldenstrom's Macroglobulinemia | ||
| NCT00890500 | Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies. | ||
| NCT06117709 | Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP) Testing | ||
| NCT06335745 | PediCARE Health Equity Intervention in High-Risk Neuroblastoma | ||
| NCT03097328 | Study of TAK-228 In Patients With Previously Treated Metastatic Renal Cell Carcinoma | ||
| NCT02269267 | The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study) | ||
| NCT06950307 | Hypofractionation for Prostate Cancer in Africa: A Feasibility Study |
